EndoU is a novel regulator of AICD during peripheral B cell selection

Journal of Experimental Medicine

Volumn 211, Issue 1, 2014, Pages 57-69

  Poe, Jonathan C ^a   Kountikov, Evgueni I ^a   Lykken, Jacquelyn M ^a   Natarajan, Abirami ^a   Marchuk, Douglas A ^a   Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD19 ANTIGEN; CD22 ANTIGEN; ENDOU PROTEIN; HEN EGG LYSOZYME; LYSOZYME; RNA BINDING PROTEIN; SINGLE STRANDED RNA; UNCLASSIFIED DRUG;

ACTIVATION INDUCED CELL DEATH; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL SELECTION; CELL SURVIVAL; CONTROLLED STUDY; GENE DISRUPTION; GENE EXPRESSION; GENE LOCUS; GENETIC IDENTIFICATION; HOMOZYGOSITY; MODIFIER GENE; MOUSE; NONHUMAN; ONCOGENE C MYC; PERIPHERAL B CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATOR GENE; SPLEEN; UPREGULATION;

ANIMALS; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL DEATH; CELL SURVIVAL; DNA PRIMERS; ENDONUCLEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION PROFILING; GENOTYPE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-MYC; QUANTITATIVE TRAIT LOCI; SELF TOLERANCE; SIALIC ACID BINDING IG-LIKE LECTIN 2; SIGNAL TRANSDUCTION;

EID: 84892527629     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20130648     Document Type: Article

References (40)

1. Baughman, G., J. Lesley, J. Trotter, R. Hyman, and S. Bourgeois. 1992. Tcl-30, a new T cell-specific gene expressed in immature glucocorticoid-sensitive thymocytes. J. Immunol. 149:1488-1496.
2. Bhardwaj, K., L. Guarino, and C.C. Kao. 2004. The severe acute respiratory syndrome coronavirus Nsp15 protein is an endoribonuclease that prefers manganese as a cofactor. J. Virol. 78:12218-12224. http://dx.doi .org/10.1128/JVI.78.22.12218-12224.2004.
3. Browne, C.D., C.J. Del Nagro, M.H. Cato, H.S. Dengler, and R.C. Rickert. 2009. Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy. Immunity. 31:749-760. http://dx.doi.org/10.1016/j.immuni.2009.08.026.
4. DeFranco, A.L., J.T. Kung, and W.E. Paul. 1982. Regulation of growth and proliferation in B cell subpopulations. Immunol. Rev. 64:161-182. http://dx.doi.org/10.1111/j.1600-065X.1982.tb00423.x.
5. Donjerkovic, D., and D.W. Scott. 2000. Activation-induced cell death in B lymphocytes. Cell Res. 10:179-192. http://dx.doi.org/10.1038/sj .cr.7290047.
6. Doody, G.M., L.B. Justement, C.C. Delibrias, R.J. Matthews, J. Lin, M.L. Thomas, and D.T. Fearon. 1995. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science. 269:242-244. http://dx.doi.org/10.1126/science.7618087.
7. Fujimoto, M., A.P. Bradney, J.C. Poe, D.A. Steeber, and T.F. Tedder. 1999. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop. Immunity. 11:191-200. http://dx.doi .org/10.1016/S1074-7613(00)80094-1.
8. Gay, D., T. Saunders, S. Camper, and M. Weigert. 1993. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177:999-1008. http://dx.doi.org/10.1084/jem.177.4.999.
9. Gijsbers, R., H. Ceulemans, and M. Bollen. 2003. Functional characterization of the non-catalytic ectodomains of the nucleotide pyrophosphatase/phosphodiesterase NPP1. Biochem. J. 371:321-330. http://dx.doi .org/10.1042/BJ20021943.
10. Gioia, U., P. Laneve, M. Dlakic, M. Arceci, I. Bozzoni, and E. Caffarelli. 2005. Functional characterization of XendoU, the endoribonuclease involved in small nucleolar RNA biosynthesis. J. Biol. Chem. 280:18996-19002. http://dx.doi.org/10.1074/jbc.M501160200.
11. Goodnow, C.C., J. Crosbie, S. Adelstein, T.B. Lavoie, S.J. Smith-Gill, R.A. Brink, H. Pritchard-Briscoe, J.S. Wotherspoon, R.H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 334:676-682. http://dx.doi.org/10.1038/334676a0.
12. Goodnow, C.C., J. Crosbie, H. Jorgensen, R.A. Brink, and A. Basten. 1989. Induction of self-tolerance in mature peripheral B lymphocytes. Nature. 342:385-391. http://dx.doi.org/10.1038/342385a0.
13. Goodnow, C.C., J.G. Cyster, S.B. Hartley, S.E. Bell, M.P. Cooke, J.I. Healy, S. Akkaraju, J.C. Rathmell, S.L. Pogue, and K.P. Shokat. 1995. Selftolerance checkpoints in B lymphocyte development. Adv. Immunol. 59: 279-368.
14. Hippen, K.L., L.E. Tze, and T.W. Behrens. 2000. CD5 maintains tolerance in anergic B cells. J. Exp. Med. 191:883-890. http://dx.doi.org/10.1084/jem.191.5.883.
15. Inaoki, M., S. Sato, B.C. Weintraub, C.C. Goodnow, and T.F. Tedder. 1997. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J. Exp. Med. 186:1923-1931. http://dx.doi.org/10.1084/jem.186.11.1923.
16. Ivanov, K.A., T. Hertzig, M. Rozanov, S. Bayer, V. Thiel, A.E. Gorbalenya, and J. Ziebuhr. 2004. Major genetic marker of nidoviruses encodes a replicative endoribonuclease. Proc. Natl. Acad. Sci. USA. 101:12694-12699. http://dx.doi.org/10.1073/pnas.0403127101.
17. Jolicoeur, P., and L. Lamontagne. 1994. Impaired T and B cell subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3. J. Immunol. 153:1318-7.
18. Lamontagne, L., J.P. Descoteaux, and P. Jolicoeur. 1989. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity. J. Immunol. 142:4458-4465.
19. Laneve, P., F. Altieri, M.E. Fiori, A. Scaloni, I. Bozzoni, and E. Caffarelli. 2003. Purification, cloning, and characterization of XendoU, a novel endoribonuclease involved in processing of intron-encoded small nucleolar RNAs in Xenopus laevis. J. Biol. Chem. 278:13026-13032. http://dx.doi .org/10.1074/jbc.M211937200.
20. Laneve, P., U. Gioia, R. Ragno, F. Altieri, C. Di Franco, T. Santini, M. Arceci, I. Bozzoni, and E. Caffarelli. 2008. The tumor marker human placental protein 11 is an endoribonuclease. J. Biol. Chem. 283:34712-34719. http://dx.doi.org/10.1074/jbc.M805759200.
21. Lei, Y., C.B. Moore, R.M. Liesman, B.P. O'Connor, D.T. Bergstralh, Z.J. Chen, R.J. Pickles, and J.P. Ting. 2009. MAVS-mediated apoptosis and its inhibition by viral proteins. PLoS ONE. 4:e5466. http://dx.doi .org/10.1371/journal.pone.0005466.
22. Manly, K.F., R.H. Cudmore Jr., and J.M. Meer. 2001. Map Manager QTX, cross-platform software for genetic mapping. Mamm. Genome. 12:930-932. http://dx.doi.org/10.1007/s00335-001-1016-3.
23. Nemazee, D.A., and K. Bürki. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature. 337:562-566. http://dx.doi.org/10.1038/337562a0.
24. Nitschke, L., R. Carsetti, B. Ocker, G. Köhler, and M.C. Lamers. 1997. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 7:133-143. http://dx.doi.org/10.1016/S0960-9822(06)00057-1.
25. Noorchashm, H., A. Bui, H.L. Li, A. Eaton, L. Mandik-Nayak, C. Sokol, K.M. Potts, E. Puré, and J. Erikson. 1999. Characterization of anergic anti-DNA B cells: B cell anergy is a T cell-independent and potentially reversible process. Int. Immunol. 11:765-776. http://dx.doi.org/10.1093/intimm/11.5.765.
26. O'Keefe, T.L., G.T. Williams, S.L. Davies, and M.S. Neuberger. 1996. Hyperresponsive B cells in CD22-deficient mice. Science. 274:798-801. http://dx.doi.org/10.1126/science.274.5288.798.
27. O'Keefe, T.L., G.T. Williams, F.D. Batista, and M.S. Neuberger. 1999. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 189:1307-1313. http://dx.doi.org/10.1084/jem.189.8.1307.
28. Otipoby, K.L., K.B. Andersson, K.E. Draves, S.J. Klaus, A.G. Farr, J.D. Kerner, R.M. Perlmutter, C.-L. Law, and E.A. Clark. 1996. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature. 384:634-637. http://dx.doi.org/10.1038/384634a0.
29. Poe, J.C., M. Fujimoto, P.J. Jansen, A.S. Miller, and T.F. Tedder. 2000. CD22 forms a quaternary complex with SHIP, Grb2 and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux. J. Biol. Chem. 275:17420-17427.
30. Poe, J.C., K.M. Haas, J. Uchida, Y. Lee, M. Fujimoto, and T.F. Tedder. 2004. Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background. J. Immunol. 172:2100-2110.
31. Poe, J.C., S.-H. Smith, K.M. Haas, K. Yanaba, T. Tsubata, T. Matsushita, and T.F. Tedder. 2011. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS ONE. 6:e22464. http://dx.doi.org/10.1371/journal.pone.0022464.
32. Poe, J.C., V. Minard-Colin, E.I. Kountikov, K.M. Haas, and T.F. Tedder. 2012. A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice. J. Immunol. 189:2318-2325. http://dx.doi.org/10.4049/jimmunol.1201000.
33. Renzi, F., E. Caffarelli, P. Laneve, I. Bozzoni, M. Brunori, and B. Vallone. 2006. The structure of the endoribonuclease XendoU: From small nucleolar RNA processing to severe acute respiratory syndrome coronavirus replication. Proc. Natl. Acad. Sci. USA. 103:12365-12370. http://dx.doi.org/10.1073/pnas.0602426103.
34. Ricagno, S., M.P. Egloff, R. Ulferts, B. Coutard, D. Nurizzo, V. Campanacci, C. Cambillau, J. Ziebuhr, and B. Canard. 2006. Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family. Proc. Natl. Acad. Sci. USA. 103:11892-11897. http://dx.doi.org/10.1073/pnas.0601708103.
35. Sato, S., A.S. Miller, M. Inaoki, C.B. Bock, P.J. Jansen, M.L.K. Tang, and T.F. Tedder. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity. 5:551-562. http://dx.doi .org/10.1016/S1074-7613(00)80270-8.
36. Shlomchik, M.J. 2008. Sites and stages of autoreactive B cell activation and regulation. Immunity. 28:18-28. http://dx.doi.org/10.1016/j.immuni.2007.12 .004.
37. Sonenshein, G.E. 1997. Down-modulation of c-myc expression induces apoptosis of B lymphocyte models of tolerance via clonal deletion. J. Immunol. 158:1994-1997.
38. Suzuki, T., A.S. Srivastava, and T. Kurokawa. 2002. A homologue of human placental protein, PP11, and mouse T cell-specific protein, Tcl-30, in exocrine pancreas of a teleost (Paralichthys olivaceus). Comp. Biochem. Physiol. B Biochem. Mol. Biol. 133:325-329. http://dx.doi.org/10.1016/S1096-4959(02)00158-6.
39. Tedder, T.F., J. Tuscano, S. Sato, and J.H. Kehrl. 1997. CD22, a B lymphocytespecific adhesion molecule that regulates antigen receptor signaling. Annu. Rev. Immunol. 15:481-504. http://dx.doi.org/10.1146/annurev .immunol.15.1.481.
40. Tiegs, S.L., D.M. Russell, and D. Nemazee. 1993. Receptor editing in selfreactive bone marrow B cells. J. Exp. Med. 177:1009-1020. http://dx.doi.org/10.1084/jem.177.4.1009.